UDG Healthcare plc (UDG) is a leading medical care facilities business based in the UK. UDG Healthcare is listed on the London Stock Exchange (LSE) and employs 9,000 staff. All prices are listed in pence sterling.
|52-week range||416.5383p - 816.9918p|
|50-day moving average||782.8677p|
|200-day moving average||746.9296p|
|Wall St. target price||10.26p|
|Dividend yield||0.13p (1.64%)|
|Earnings per share (TTM)||36.8p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing UDG Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of UDG Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
UDG Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, UDG Healthcare shares trade at around 21x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
UDG Healthcare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.21. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into UDG Healthcare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
UDG Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £185.9 million.
The EBITDA is a measure of a UDG Healthcare's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£1.3 billion|
|Operating margin TTM||10.22%|
|Gross profit TTM||£398.2 million|
|Return on assets TTM||4.92%|
|Return on equity TTM||9.85%|
|Market capitalisation||£1.9 billion|
TTM: trailing 12 months
Dividend payout ratio: 45.59% of net profits
Recently UDG Healthcare has paid out, on average, around 45.59% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.64% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), UDG Healthcare shareholders could enjoy a 1.64% return on their shares, in the form of dividend payments. In UDG Healthcare's case, that would currently equate to about 0.13p per share.
While UDG Healthcare's payout ratio might seem fairly standard, it's worth remembering that UDG Healthcare may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 January 2021 (the "ex-dividend date").
UDG Healthcare's shares were split on a 32:5 basis on 21 July 2003. So if you had owned 5 shares the day before before the split, the next day you'd have owned 32 shares. This wouldn't directly have changed the overall worth of your UDG Healthcare shares – just the quantity. However, indirectly, the new 84.4% lower share price could have impacted the market appetite for UDG Healthcare shares which in turn could have impacted UDG Healthcare's share price.
Over the last 12 months, UDG Healthcare's shares have ranged in value from as little as 416.5383p up to 816.9918p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while UDG Healthcare's is 0.6282. This would suggest that UDG Healthcare's shares are less volatile than average (for this exchange).
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is heaquartered in Dublin, the Republic of Ireland.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.